Mural Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Mural Oncology has a total shareholder equity of $174.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $203.3M and $29.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$175.50m |
| Equity | US$174.14m |
| Total liabilities | US$29.13m |
| Total assets | US$203.27m |
Recent financial health updates
Here's Why We're Watching Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Nov 26
Here's Why We're A Bit Worried About Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Jul 17We're Keeping An Eye On Mural Oncology's (NASDAQ:MURA) Cash Burn Rate
Mar 28Recent updates
Here's Why We're Watching Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Nov 26Here's Why We're A Bit Worried About Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Jul 17We're Keeping An Eye On Mural Oncology's (NASDAQ:MURA) Cash Burn Rate
Mar 28Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value
Mar 04Financial Position Analysis
Short Term Liabilities: MURA's short term assets ($183.8M) exceed its short term liabilities ($24.9M).
Long Term Liabilities: MURA's short term assets ($183.8M) exceed its long term liabilities ($4.2M).
Debt to Equity History and Analysis
Debt Level: MURA is debt free.
Reducing Debt: MURA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MURA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MURA has sufficient cash runway for 1.6 years if free cash flow continues to grow at historical rates of 1.6% each year.